PTH
Invesco Dorsey Wright Healthcare Momentum ETF
1W: +1.4%
1M: -3.2%
3M: -4.3%
YTD: -1.9%
1Y: +17.1%
3Y: +28.5%
5Y: -11.7%
$48.19
+0.30 (+0.63%)
After Hours: $49.15 (+0.96, +2.00%)
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Weather
ETF-Level Metrics
AUM$128M
Holdings58
Top 10 Wt39.9%
Beta1.41
% Profitable26%
Coverage100%
Portfolio Valuation
P/E34.2
P/B10.4
P/S2.9
EV/EBITDA18.1
P/FCF27.3
PEG1.17
Profitability & Returns
Gross Margin41.7%
Net Margin3.1%
ROE11.2%
ROA2.8%
ROIC11.8%
Div Yield0.02%
Leverage & Liquidity
Debt/Equity2.20
Debt/Assets0.54
Net Debt/EBITDA2.0x
Interest Cov3.4x
Current Ratio1.94
Quick Ratio1.83
Growth (YoY)
Revenue+44.5%
Net Income+10.7%
EPS+16.6%
FCF+26.9%
EBITDA+8.5%
Rev CAGR 3Y+47.7%
Quality Scores
Piotroski F4.6
Altman Z15.78
IS Quality51.7
IS Overall50.0
IS Value35.5
Median P/E-12.7
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 56 | 98.1% | -110.3 |
| Financial Services | 2 | 1.9% | 26.4 |
Smart Money Overlap
0 holdings with signalsNo holdings with active convergence signals
Showing 50 of 58 holdings
· Page 1 of 2
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Terns Pharmaceuticals Inc | TERN | 6.09% | $7.1M | 144,426 | -51.6 | $4.8B | Healthcare |
| 2 | Roivant Sciences Ltd | ROIV | 5.59% | $6.5M | 234,179 | -23.6 | $19.6B | Healthcare |
| 3 | Praxis Precision Medicines Inc | PRAX | 5.15% | $6.0M | 20,146 | -22.5 | $6.4B | Healthcare |
| 4 | Guardant Health Inc | GH | 3.57% | $4.2M | 46,622 | -27.2 | $11.6B | Healthcare |
| 5 | Arrowhead Pharmaceuticals Inc | ARWR | 3.52% | $4.1M | 72,012 | 42.1 | $8.5B | Healthcare |
| 6 | Revolution Medicines Inc | RVMD | 3.47% | $4.0M | 40,722 | -15.7 | $18.5B | Healthcare |
| 7 | Tenet Healthcare Corp | THC | 3.29% | $3.8M | 18,702 | 12.2 | $17.2B | Healthcare |
| 8 | Natera Inc | NTRA | 3.19% | $3.7M | 18,327 | -128.8 | $27.8B | Healthcare |
| 9 | Celcuity Inc | CELC | 3.00% | $3.5M | 30,873 | -34.1 | $5.3B | Healthcare |
| 10 | HCA Healthcare Inc | HCA | 2.99% | $3.5M | 6,955 | 16.3 | $107.4B | Healthcare |
| 11 | United Therapeutics Corp | UTHR | 2.94% | $3.4M | 6,503 | 17.7 | $23.3B | Healthcare |
| 12 | Axsome Therapeutics Inc | AXSM | 2.56% | $3.0M | 18,775 | -45.4 | $8.4B | Healthcare |
| 13 | Protagonist Therapeutics Inc | PTGX | 2.43% | $2.8M | 27,871 | -49.9 | $6.5B | Healthcare |
| 14 | Bridgebio Pharma Inc | BBIO | 2.34% | $2.7M | 38,801 | -19.6 | $14.1B | Healthcare |
| 15 | Medpace Holdings Inc | MEDP | 2.28% | $2.7M | 5,762 | 29.3 | $13.2B | Healthcare |
| 16 | Ensign Group Inc/The | ENSG | 2.28% | $2.7M | 13,115 | 33.8 | $11.7B | Healthcare |
| 17 | Cogent Biosciences Inc | COGT | 2.25% | $2.6M | 75,620 | -7.6 | $6.0B | Healthcare |
| 18 | Madrigal Pharmaceuticals Inc | MDGL | 2.23% | $2.6M | 5,728 | -40.4 | $11.9B | Healthcare |
| 19 | BrightSpring Health Services Inc | BTSG | 2.16% | $2.5M | 57,292 | 45.5 | $8.3B | Healthcare |
| 20 | Stoke Therapeutics Inc | STOK | 2.06% | $2.4M | 72,336 | -285.8 | $2.0B | Healthcare |
| 21 | Travere Therapeutics Inc | TVTX | 1.88% | $2.2M | 78,859 | -50.2 | $2.6B | Healthcare |
| 22 | PACS Group Inc | PACS | 1.69% | $2.0M | 56,734 | 26.4 | $5.1B | Financial Services |
| 23 | Alignment Healthcare Inc | ALHC | 1.46% | $1.7M | 93,552 | -4624.7 | $3.5B | Healthcare |
| 24 | Harrow Inc | HROW | 1.42% | $1.7M | 48,135 | -253.1 | $1.3B | Healthcare |
| 25 | Taysha Gene Therapies Inc | TSHA | 1.42% | $1.6M | 361,264 | -12.7 | $1.1B | Healthcare |
| 26 | Mirum Pharmaceuticals Inc | MIRM | 1.34% | $1.6M | 17,210 | -191.0 | $4.5B | Healthcare |
| 27 | Ligand Pharmaceuticals Inc | LGND | 1.34% | $1.6M | 7,384 | 32.3 | $4.1B | Healthcare |
| 28 | Immunome Inc | IMNM | 1.32% | $1.5M | 74,001 | -8.4 | $1.8B | Healthcare |
| 29 | Palvella Therapeutics Inc | PVLA | 1.27% | $1.5M | 12,988 | -39.5 | $1.4B | Healthcare |
| 30 | Kymera Therapeutics Inc | KYMR | 1.25% | $1.5M | 18,235 | -21.7 | $6.5B | Healthcare |
| 31 | Arcutis Biotherapeutics Inc | ARQT | 1.24% | $1.4M | 63,193 | -177.8 | $2.8B | Healthcare |
| 32 | PTC Therapeutics Inc | PTCT | 1.21% | $1.4M | 20,932 | 7.9 | $5.5B | Healthcare |
| 33 | Tarsus Pharmaceuticals Inc | TARS | 1.20% | $1.4M | 20,954 | -43.3 | $2.9B | Healthcare |
| 34 | Ideaya Biosciences Inc | IDYA | 1.19% | $1.4M | 42,601 | -25.0 | $2.8B | Healthcare |
| 35 | Alphatec Holdings Inc | ATEC | 1.00% | $1.2M | 91,834 | -12.1 | $1.7B | Healthcare |
| 36 | Amneal Pharmaceuticals Inc | AMRX | 1.00% | $1.2M | 93,880 | 52.4 | $3.8B | Healthcare |
| 37 | Nuvation Bio Inc | NUVB | 0.97% | $1.1M | 265,946 | -7.4 | $1.5B | Healthcare |
| 38 | Maze Therapeutics Inc | MAZE | 0.96% | $1.1M | 22,647 | -10.4 | $1.5B | Healthcare |
| 39 | Axogen Inc | AXGN | 0.96% | $1.1M | 35,781 | -96.4 | $1.7B | Healthcare |
| 40 | AnaptysBio Inc | ANAB | 0.95% | $1.1M | 17,090 | -136.5 | $1.9B | Healthcare |
| 41 | Kodiak Sciences Inc | KOD | 0.94% | $1.1M | 48,254 | -9.7 | $2.1B | Healthcare |
| 42 | Oruka Therapeutics Inc | ORKA | 0.92% | $1.1M | 27,605 | -23.5 | $1.7B | Healthcare |
| 43 | Trevi Therapeutics Inc | TRVI | 0.86% | $998,963 | 93,361 | -40.2 | $1.5B | Healthcare |
| 44 | Relay Therapeutics Inc | RLAY | 0.84% | $978,780 | 97,878 | -6.3 | $1.8B | Healthcare |
| 45 | Replimune Group Inc | REPL | 0.83% | $962,967 | 139,763 | -2.2 | $623M | Healthcare |
| 46 | Zymeworks Inc | ZYME | 0.72% | $843,446 | 35,298 | -22.9 | $1.8B | Healthcare |
| 47 | Precigen Inc | PGEN | 0.71% | $827,988 | 249,394 | -4.9 | $1.2B | Healthcare |
| 48 | Sionna Therapeutics Inc | SION | 0.71% | $826,456 | 23,287 | -20.2 | $1.7B | Healthcare |
| 49 | Monte Rosa Therapeutics Inc | GLUE | 0.70% | $814,563 | 50,720 | -26.6 | $1.0B | Healthcare |
| 50 | Annexon Inc | ANNX | 0.69% | $800,310 | 145,776 | -3.8 | $628M | Healthcare |